As of 2025-05-15, the Fair Value of Gracell Biotechnologies Inc (GRCL) is -4.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.25 USD, the upside of Gracell Biotechnologies Inc is -142.24%.
With the market price of 10.25 USD and our fair value calculation, Gracell Biotechnologies Inc (GRCL) is not a good investment. Investing in GRCL stocks now will result in a potential loss of 142.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -138.66 | -211.90 | -451.75 | -607.51 | -352.46 | |
| YoY growth | -128.10% | -52.82% | -113.19% | -34.48% | -82.15% | |
| Market Cap (mil) | 983.25 |
| P/E | |
| Forward P/E |
| EPS | -6.27 |
| Avg earnings growth rate | -82.15% |
| TTM earnings | -601.28 |